In last trading session, Bionomics Ltd. ADR (NASDAQ:BNOX) saw 13.56 million shares changing hands with its beta currently measuring 0.11. Company’s recent per share price level of $0.38 trading at $0.1 or 36.25% at ring of the bell on the day assigns it a market valuation of $5.03M. That closing price of BNOX’s stock is at a discount of -647.37% from its 52-week high price of $2.84 and is indicating a premium of 52.63% from its 52-week low price of $0.18. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 55.66 million shares which gives us an average trading volume of 8.74 million if we extend that period to 3-months.
For Bionomics Ltd. ADR (BNOX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bionomics Ltd. ADR (NASDAQ:BNOX) trade information
Upright in the green during last session for gaining 36.25%, in the last five days BNOX remained trading in the green while hitting it’s week-highest on Tuesday, 11/05/24 when the stock touched $0.38 price level, adding 38.59% to its value on the day. Bionomics Ltd. ADR’s shares saw a change of -74.32% in year-to-date performance and have moved 90.95% in past 5-day. Bionomics Ltd. ADR (NASDAQ:BNOX) showed a performance of 35.23% in past 30-days. Number of shares sold short was 13778.0 shares which calculate 0.05 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 6 to the stock, which implies a rise of 93.67% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -1478.95% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1478.95% for stock’s current value.
Bionomics Ltd. ADR (BNOX) estimates and forecasts
Statistics highlight that Bionomics Ltd. ADR is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -60.56% of value to its shares in past 6 months, showing an annual growth rate of 18.08% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 14.53% during past 5 years.
Bionomics Ltd. ADR (NASDAQ:BNOX)’s Major holders
ARMISTICE CAPITAL, LLC is the top institutional holder at BNOX for having 1.23 million shares of worth $0.94 million. And as of 2024-06-30, it was holding 12.9314 of the company’s outstanding shares.
The second largest institutional holder is LYNX1 CAPITAL MANAGEMENT LP, which was holding about 0.6 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.3212 of outstanding shares, having a total worth of $0.46 million.
